Results 101 to 110 of about 11,403 (144)
C-Reactive Protein Response in Patients With Post-Treatment Lyme Disease Symptoms Versus Those With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. [PDF]
Clin Infect Dis, 2018 Uhde M +6 more
europepmc +1 more source
Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2. [PDF]
Healthcare (Basel), 2018 Horowitz RI, Freeman PR.
europepmc +1 more source
Sex and menopause-based differences in presentation of early Lyme disease: A prospective cohort study. [PDF]
Clin Exp MedRebman AW, Yang T, Aucott JN.
europepmc +1 more source
Lyme in the prosthetic joint: two cases and a review of the literature. [PDF]
J Bone Jt InfectTabaja H +4 more
europepmc +1 more source
Post-Exposure Prophylaxis Prescribing Practices in a Lyme Disease-Endemic Area. [PDF]
Infect Dis RepLee EB, Schotthoefer A, Whitfield P.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical Reviews in Allergy & Immunology, 2021
Lyme disease is an infection caused by Borrelia burgdorferi sensu lato, which is transmitted to humans through the bite of an infected Ixodes tick. The majority of patients recover without complications with antibiotic therapy. However, for a minority of patients, accompanying non-specific symptoms can persist for months following completion of therapy.
Katelyn H. Wong +2 more
openaire +2 more sources
Lyme disease is an infection caused by Borrelia burgdorferi sensu lato, which is transmitted to humans through the bite of an infected Ixodes tick. The majority of patients recover without complications with antibiotic therapy. However, for a minority of patients, accompanying non-specific symptoms can persist for months following completion of therapy.
Katelyn H. Wong +2 more
openaire +2 more sources
Autoantibodies in post-treatment Lyme disease and association with clinical symptoms
Clinical and Experimental Rheumatology, 2023Autoantibodies have been described in the post-infectious state, specifically after Lyme disease and COVID-19. We aimed to describe the prevalence and potential clinical utility of several commercially available autoantibodies after these infections.Euroimmun panels (myositis, scleroderma and ANA5) were assayed using sera from patients with Lyme ...
Marzieh, Keshtkarjahromi +7 more
openaire +2 more sources